These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23143553)

  • 21. Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis.
    Xu Y; Yang CS; Li YJ; Liu XD; Wang JN; Zhao Q; Xiao WG; Yang PT
    Clin Rheumatol; 2016 Jan; 35(1):113-6. PubMed ID: 26660480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.
    Fujisawa T; Hozumi H; Kono M; Enomoto N; Nakamura Y; Inui N; Nakashima R; Imura Y; Mimori T; Suda T
    Respir Investig; 2017 Mar; 55(2):130-137. PubMed ID: 28274528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis.
    Kobayashi N; Takezaki S; Kobayashi I; Iwata N; Mori M; Nagai K; Nakano N; Miyoshi M; Kinjo N; Murata T; Masunaga K; Umebayashi H; Imagawa T; Agematsu K; Sato S; Kuwana M; Yamada M; Takei S; Yokota S; Koike K; Ariga T
    Rheumatology (Oxford); 2015 May; 54(5):784-91. PubMed ID: 25288783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gottron Papules and Gottron Sign with Ulceration: A Distinctive Cutaneous Feature in a Subset of Patients with Classic Dermatomyositis and Clinically Amyopathic Dermatomyositis.
    Cao H; Xia Q; Pan M; Zhao X; Li X; Shi R; Zhou M; Ding X; Kuwana M; Zheng J
    J Rheumatol; 2016 Sep; 43(9):1735-42. PubMed ID: 27307530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease.
    Go DJ; Park JK; Kang EH; Kwon HM; Lee YJ; Song YW; Lee EB
    Rheumatol Int; 2016 Jan; 36(1):125-31. PubMed ID: 26223808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140/MDA5 antibody positive amyopathic dermatomyositis.
    Takada T; Aoki A; Asakawa K; Sakagami T; Moriyama H; Narita I; Sato S
    Respir Med; 2015 Sep; 109(9):1174-80. PubMed ID: 26187000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report.
    Cao M; Zhang S; Chu D; Xiao M; Liu X; Yu L; Li J; Huang Y; Fang F
    BMC Pulm Med; 2020 Nov; 20(1):304. PubMed ID: 33213393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early pulmonary involvement of anti-CADM-140 autoantibody-positive rapidly progressive interstitial lung disease preceding typical cutaneous symptoms.
    Tamai K; Tachikawa R; Otsuka K; Ueda H; Hosono Y; Tomii K
    Intern Med; 2014; 53(21):2515-9. PubMed ID: 25366013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease.
    Nara M; Komatsuda A; Omokawa A; Togashi M; Okuyama S; Sawada K; Wakui H
    Mod Rheumatol; 2014 Jul; 24(4):633-6. PubMed ID: 24252021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dermatomyositis and Polymyositis in the Intensive Care Unit: A Single-Center Retrospective Cohort Study of 102 Patients.
    Peng JM; Du B; Wang Q; Weng L; Hu XY; Wu CY; Shi Y
    PLoS One; 2016; 11(4):e0154441. PubMed ID: 27115138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis.
    Sakamoto N; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kitazaki T; Kakugawa T; Ishimatsu Y; Satoh M; Mukae H
    Intern Med; 2019 Mar; 58(6):837-841. PubMed ID: 30449789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical features and risk factors associated with interstitial lung disease in patients with classic dermatomyositis or clinical amyopathic dermatomyositis].
    Lin H; Liang Y; Wang Y; Cen XM; Yin G; Xie QB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):805-9. PubMed ID: 24325117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy.
    Bai Z; Shen G; Dong L
    Int J Rheum Dis; 2021 Jun; 24(6):815-827. PubMed ID: 34028988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Risk Factors of Respiratory Failure in the Dermatomyositis Patients with Interstitial Lung Disease].
    Zhang SH; Peng Y; Xie QB; Yin G; Yan B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 49(2):188-194. PubMed ID: 29737058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of anti-melanoma differentiation associated gene 5 (MDA5) IgG subclasses in MDA5+ dermatomyositis.
    Chen M; Zhao Q; Diao L; Xue K; Ruan Y; Xue F; Li J; Shi R; Pan M; Zheng J; Cao H
    Rheumatology (Oxford); 2021 Dec; 61(1):430-439. PubMed ID: 33742662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-treatment ferritin level and alveolar-arterial oxygen gradient can predict mortality rate due to acute/subacute interstitial pneumonia in dermatomyositis treated by cyclosporine a/glucocorticosteroid combination therapy: a case control study [corrected].
    Isoda K; Takeuchi T; Kotani T; Hata K; Shoda T; Ishida T; Yoshida S; Kimura Y; Makino S; Hanafusa T
    PLoS One; 2014; 9(2):e89610. PubMed ID: 24586910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful polymyxin B hemoperfusion treatment associated with serial reduction of serum anti-CADM-140/MDA5 antibody levels in rapidly progressive interstitial lung disease with amyopathic dermatomyositis.
    Teruya A; Kawamura K; Ichikado K; Sato S; Yasuda Y; Yoshioka M
    Chest; 2013 Dec; 144(6):1934-1936. PubMed ID: 24297126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokeratin 19 fragment is associated with severity and poor prognosis of interstitial lung disease in anti-MDA5 antibody-positive dermatomyositis.
    Gui X; Ma M; Ding J; Shi S; Xin X; Qiu X; Zhang Y; Qiu Y; Cao M; Huang M; Cao M; Dai J; Cai H; Xiao Y
    Rheumatology (Oxford); 2021 Aug; 60(8):3913-3922. PubMed ID: 33501503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Mortality in Autoimmune Myositis With and Without Associated Interstitial Lung Disease.
    Johnson C; Pinal-Fernandez I; Parikh R; Paik J; Albayda J; Mammen AL; Christopher-Stine L; Danoff S
    Lung; 2016 Oct; 194(5):733-7. PubMed ID: 27166633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulation of the type I interferon system in adult-onset clinically amyopathic dermatomyositis has a potential contribution to the development of interstitial lung disease.
    Sun WC; Sun YC; Lin H; Yan B; Shi GX
    Br J Dermatol; 2012 Dec; 167(6):1236-44. PubMed ID: 23013528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.